Back to WA Wealthspire Advisors, LLC

REGNREGN
Showing 8 of 23 quarters

Position history for WAWealthspire Advisors, LLC's holdings in REGENERON PHARMACEUTICALS

Wealthspire Advisors, LLC holds 7,042 shares of REGN (REGENERON PHARMACEUTICALS), worth $4.4M as of 2026-Q2. The position was decreased (-19.1% shares). REGN represents 0.0% of Wealthspire Advisors, LLC's portfolio.

Current Value

$4.4M

Current Shares

7,042

Total Value Change

-$4.1M

Total Shares Change

-1,070

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
7,042
-19.1%
$4.4M0.0%$623.54
0
2026-Q1
Increased
8,706
+168.5%
$6.7M0.1%$766.66
44
2025-Q4
Increased
3,243
+8.7%
$2.5M0.0%$773.94
28
2025-Q3
Decreased
2,984
-51.4%
$1.7M0.0%$560.05
0
2025-Q2
Decreased
6,137
-34.4%
$3.2M0.0%$519.56
0
2025-Q1
Increased
9,350
+66.4%
$5.9M0.0%$634.66
40
2024-Q4
Decreased
5,619
-30.7%
$4M0.0%$698.71
0
2024-Q3
Increased
8,112
+1629.6%
$8.5M0.1%$1,036.94
44

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used